Crinetics Pharmaceuticals, Inc. (CRNX) — Analysis Summary
Crinetics Pharmaceuticals, Inc. (CRNX) has a market cap of $3.70B with year-over-year revenue growth of +640.7%. Net margin stands at -6046.2%. The stock trades at a P/E ratio of -7.5.
Key Takeaways
- Revenue changed +640.7% year-over-year
- Net margin of -6046.2%
- P/E ratio of -7.5
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, CRNX posted revenue growth of +640.7% and trades at a P/E of -7.5.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.